Polypharmacy is the use of multiple potentially unnecessary medications mainly by elderly patients. It can be associated with an increased risk of adverse drug events, and may also burden the medical economy. Hospitalization is a good opportunity to review medications of elderly patients. Pharmacists are required to assess the appropriateness of therapy, including the dosage, administration schedule, and ongoing need for therapy of all hospitalized patients' medicines.
To identify the problems related to polypharmacy, we examined “pre-avoid”(adverse effect evasion case reports advocated by the Japanese Society of Hospital Pharmacists) reports related to dose reduction or medication discontinuation that occurred in Kyushu Hospital from June 2010 to October 2015.
We identified 488 reports, of which, 71.9% cases involved medications used by patients who were at least 70 years old. Abnormal laboratory values were observed in 58.6% of these cases and were the main reasons that doses were decreased or drugs discontinued. Duplicate therapy was reported in 20.9% cases. A few of the pharmacist-assessed reports described adverse drug reactions or reductions in unnecessary medications. Therefore, we conclude that pharmaceutical care was reasonable in terms of comprehensive assessment, dose adjustment, and prevention of duplicate therapy. In contrast, there were still problems related to polypharmacy such as assessment of the necessity of medication and reductions in the number of pills taken by an elderly patient.
It is important to identify patients who are using potentially inappropriate medications, and to predict the risk of adverse drug reactions. These efforts will help pharmacists identify adverse drug reactions at an early stage and reduce inappropriate polypharmacy.
View full abstract